But Pfizer has said it did not test the ‘alternative’ dosing regimen.
AstraZeneca is investigating whether a patient’s reported side effect is connected with the vaccine.
More from us
Did you know with a Plus subscription to Shropshire Star you get full access to our award winning journalism for the news that matters to you and more.